KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Payables: 2018-2025

Historic Payables for BioNTech SE (BNTX) over the last 6 years, with Sep 2025 value amounting to $456.4 million.

  • BioNTech SE's Payables fell 45.34% to $456.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 billion, marking a year-over-year decrease of 22.26%. This contributed to the annual value of $453.5 million for FY2024, which is 19.10% up from last year.
  • BioNTech SE's Payables amounted to $456.4 million in Q3 2025, which was down 18.71% from $561.5 million recorded in Q2 2025.
  • Over the past 5 years, BioNTech SE's Payables peaked at $946.8 million during Q2 2024, and registered a low of -$21.1 million during Q1 2022.
  • Over the past 3 years, BioNTech SE's median Payables value was $455.0 million (recorded in 2024), while the average stood at $491.2 million.
  • In the last 5 years, BioNTech SE's Payables slumped by 2,398.91% in 2022 and then soared by 1,378.36% in 2023.
  • Over the past 5 years, BioNTech SE's Payables (Quarterly) stood at $331.6 million in 2021, then tumbled by 37.21% to $208.2 million in 2022, then surged by 82.86% to $380.8 million in 2023, then rose by 19.10% to $453.5 million in 2024, then slumped by 45.34% to $456.4 million in 2025.
  • Its Payables stands at $456.4 million for Q3 2025, versus $561.5 million for Q2 2025 and $462.1 million for Q1 2025.